Cargando…
Hormone therapy and melanoma in women
Although primary cutaneous melanoma accounts for approximately 3% of all malignant skin tumors, it has the greatest contribution to skin cancer–related death. Sex-specific differences in melanoma tumor behavior have been described, and melanoma pathogenesis may be hormonally mediated. This review ai...
Autores principales: | Hill, Madison S., Cartron, Alexander M., Burgoyne, Mary, Driscoll, Marcia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714603/ https://www.ncbi.nlm.nih.gov/pubmed/35028367 http://dx.doi.org/10.1016/j.ijwd.2021.06.005 |
Ejemplares similares
-
Prognosis for women diagnosed with melanoma during, before, or after pregnancy: Weighing the evidence
por: Todd, Sarah P., et al.
Publicado: (2017) -
Comorbidities of hidradenitis suppurativa: A review of the literature
por: Cartron, Alexander, et al.
Publicado: (2019) -
A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause
por: Madsen, Tracy E, et al.
Publicado: (2023) -
Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005) -
Cutaneous melanoma in women()
por: Roh, Mi Ryung, et al.
Publicado: (2015)